Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder

Frontiers in Cellular Neuroscience

Volumn 8, Issue , 2014, Pages

  Pinna, Graziano ^a   Rasmusson, Ann M ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 Reductase type I; Allopregnanolone; Anxiety disorders; GABAA receptor; Ganaxolone; PTSD; PTSD therapy; Selective brain steroidogenic stimulants

Indexed keywords

GANAXOLONE;

ADULT; AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CONDITIONING; CONTEXTUAL FEAR CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; EC50; ELEVATED PLUS MAZE TEST; EXPERIMENTAL BEHAVIORAL TEST; EXPLORATORY BEHAVIOR; FOOTSHOCK; FREEZING; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; POSTTRAUMATIC STRESS DISORDER; RESIDENT INTRUDER TEST;

EID: 84907193857     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00256     Document Type: Article

References (108)

1. Agis-Balboa, R. C., Guidotti, A., and Pinna, G. (2014). 5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients. Psychopharmacology (Berl.) doi: 10.1007/s00213-014-3567-5 [Epub ahead of print].
2. Agís-Balboa, R. C., Pinna, G., Pibiri, F., Kadriu, B., Costa, E., and Guidotti, A. (2007). Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice. Proc. Natl. Acad. Sci. U.S.A. 104, 18736-18741. doi: 10.1073/pnas.0709419104
3. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th Edn. Arlington, VA: American Psychiatric Publishing.
4. Belelli, D., and Lambert, J. J. (2005). Neurosteroids: endogenous regulators of the GABA receptor. Nat. Rev. Neurosci. 6, 565-575. doi: 10.1038/nrn1703
5. Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., and White, H. S. (2013). Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI). Epilepsy Res. 103, 2-30. doi: 10.1016/j.eplepsyres.2012.10.001
6. Brady, K., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., Sikes, C.,et al. (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder. JAMA 283, 1837-1844. doi: 10.1001/jama.283.14.1837
7. Braga, M. F., Aroniadou-Anderjaska, V., Manion, S. T., Hough, C. J., and Li, H. (2004). Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala.Neuropsychopharmacology 29, 45-58. doi: 10.1038/sj.npp.1300297
8. Bremner, J. D., Innis, R. B., Southwick, S. M., Staib, L., Zoghbi, S., and Charney, D. S. (2000). Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am. J. Psychiatry 157, 1120-1126. doi: 10.1176/appi.ajp.157.7.1120
9. Bustos, S. G., Maldonado, H., and Molina, V. A. (2006). Midazolam disrupts fear memory reconsolidation.Neuroscience 139, 831-842. doi: 10.1016/j.neuroscience.2005.12.064
10. Carlson, K. F., Kehle, S. M., Meis, L. A., Greer, N., Macdonald, R., Rutks, I.,et al. (2011). Prevalence, assessment, and treatment of mild traumatic brain injury and posttraumatic stress disorder: a systematic review of the evidence. J. Head Trauma Rehabil. 26, 103-115. doi: 10.1097/HTR.0b013e3181e50ef1
11. Chhatwal, J. P., Myers, K. M., Ressler, K. J., and Davis, M. (2005). Regulation of gephyrin and GABA receptor binding within the amygdala after fear acquisition and extinction. J. Neurosci. 25, 502-506. doi: 10.1523/JNEUROSCI.3301-04.2005
12. Costa, E., Auta, J., Guidotti, A., Korneyev, A., and Romeo, E. (1994). The pharmacology of neurosteroidogenesis. J. Steroid Biochem. Mol. Biol. 49, 385-389. doi: 10.1016/0960-0760(94)90284-4
13. Costa, E., and Guidotti A. (1991). Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci. 49, 325-344. doi: 10.1016/0024-3205(91)90440-M
14. Costanzi, M., Battaglia, M., Populin, R., Cestari, V., and Castellano, C. (2003). Anandamide and memory in CD1 mice: effects of immobilization stress and of prior experience. Neurobiol. Learn. Mem. 79, 204-211. doi: 10.1016/S1074-7427(03)00006-6
15. Davidson, J., Baldwin, D., Stein, D. J., Kuper, E., Benattia, I., Ahmed, S.,et al. (2006). Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch. Gen. Psychiatry63 , 1158-1165. doi: 10.1001/archpsyc.63.10.1158
16. Davidson, J. R. T., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., and Farfel, G. M. (2001). Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch. Gen. Psychiatry 58, 485-492. doi: 10.1001/archpsyc.58.5.485
17. Dong, E., Matsumoto, K., Uzunova, V., Sugaya, I., Costa, E., and Guidotti, A. (2001). Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc. Natl. Acad. Sci. U.S.A. 98, 2849-2854. doi: 10.1073/pnas.051628598
18. Dussault, I., and Forman, B. M. (2002). The nuclear receptor PXR: a master regulator of "homeland" defense. Crit. Rev. Eukaryot. Gene Expr. 12, 53-64. doi: 10.1615/CritRevEukaryotGeneExpr.v12.i1.30
19. Duvarci, S., and Nader, K. (2004). Characterization of fear memory reconsolidation. J. Neurosci. 24 , 9269-9275. doi: 10.1523/JNEUROSCI.2971-04.2004
20. Follesa, P., Cagetti, E., Mancuso, L., Biggio, F., Manca, A., Maciocco, E.,et al. (2001). Increase in expression of the GABA(A) receptor alpha(4) subunit gene induced by withdrawal of, but not by long-term treatment with, benzodiazepine full or partial agonists. Brain Res. Mol. Brain Res. 92, 138-148. doi: 10.1016/S0169-328X(01)00164-4
21. Forman, B. M., Chen, J., and Evans, R. M. (1996). The peroxisome proliferator-activated receptors: ligands and activators. Ann. N. Y. Acad. Sci. 804, 266-275. doi: 10.1111/j.1749-6632.1996.tb18621.x
22. Francis, G. A., Fayard, E., Picard, F., and Auwerx, J. (2002). Nuclear receptors and the control of metabolism.Annu. Rev. Physiol. 65, 261-311. doi: 10.1146/annurev.physiol.65.092101.142528
23. Friedman, M. J., Keane T. M., Resick, P. A. (eds). (2014). Handbook of PTSD, 2nd Edn. New York, NY: Guilford Publications, Inc.
24. Friedman, M. J., Marmar, C. R., Baker, D. G., Sikes, C. R., and Farfel, G. M. (2007). Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.J. Clin. Psychiatry 68, 711-720. doi: 10.4088/JCP.v68n0508
25. Frye, C. A. (2011). Novel substrates for, and sources of, progestogens for reproduction. J. Neuroendocrinol. 23, 961-973. doi: 10.1111/j.1365-2826.2011.02180.x
26. Frye, C. A., Koonce, C. J., and Walf, A. A. (2014). The pregnane xenobiotic receptor, a prominent liver factor, has actions in the midbrain for neurosteroid synthesis and behavioral/neural plasticity of female rats. Front. Syst. Neurosci. 8:60. doi: 10.3389/fnsys.2014.00060
27. Frye, C. A., Koonce, C. J., Walf, A. A., and Rusconi, J. C. (2013). Motivated behaviors and levels of 3α,5α-THP in the midbrain are attenuated by knocking down expression of pregnane xenobiotic receptor in the midbrain ventral tegmental area of proestrous rats. J. Sex. Med. 10, 1692-1706. doi: 10.1111/jsm.12173
28. Frye, C. A., Paris, J. J., Walf, A. A., and Rusconi, J. C. (2012). Effects and mechanisms of 3α,5α,-THP on emotion, motivation, and reward functions involving pregnane xenobiotic receptor. Front. Neurosci. 5:136. doi: 10.3389/fnins.2011.00136
29. Gafford, G. M., Guo, J. D., Flandreau, E. I., Hazra, R., Rainnie, D. G., and Ressler, K. J. (2012). Cell-type specific deletion of GABA(A)alpha1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction. Proc. Natl. Acad. Sci. U.S.A. 109, 16330-16335. doi: 10.1073/pnas.1119261109
30. Geick, A., Eichelbaum, M., and Burk, O. (2001). Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 276, 14581-14587. doi: 10.1074/jbc.M010173200
31. Geuze, E., van Berckel, B. N., Lammertsma, A. A., Boellaard, R., de Kloet, C. S., Vermetten, E.,et al. (2008). Reduced GABA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol. Psychiatry 13, 74-83. doi: 10.1038/sj.mp.4002054
32. Gillespie, C. F., Almli, L. M., Smith, A. K., Bradley, B., Kerley, K., Crain, D. F.,et al. (2013). Sex dependent influence of a functional polymorphism in steroid 5-alpha-reductase type 2 (SRD5A2) on post-traumatic stress symptoms.Am. J. Med. Genet. B Neuropsychiatr. Genet. 162, 283-292. doi: 10.1002/ajmg.b.32147
33. Gulinello, M., Gong, Q. H., and Smith, S. S. (2002). Progesterone withdrawal increases the alpha4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology: a comparison with female rats. Neuropharmacology 43, 701-714. doi: 10.1016/S0028-3908(02)00171-5
34. Gulinello, M., Gong, Q. H., and Smith, S. S. (2003). Progesterone withdrawal increases the anxiolytic actions of gaboxadol: role of alpha4betadelta GABA(A) receptors. Neuroreport 14, 43-46. doi: 10.1097/00001756-200301200-00008
35. Heldt, S. A., Mou, L., and Ressler, K. J. (2012). In vivo knockdown of GAD67 in the amygdala disrupts fear extinction and the anxiolytic-like effect of diazepam in mice. Transl. Psychiatry 2, e181. doi: 10.1038/tp.2012.101
36. Heldt, S. A., and Ressler, K. J. (2007). Training-induced changes in the expression of GABA-associated genes in the amygdala after the acquisition and extinction of Pavlovian fear. Eur. J. Neurosci. 26, 3631-3644. doi: 10.1111/j.1460-9568.2007.05970.x
37. Hertzberg, M. A., Feldman, M. E., Beckham, J. C., Kudler, H. S., and Davidson, J. R. (2000). Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann. Clin. Psychiatry 12, 101-105. doi: 10.3109/10401230009147096
38. Hill, M. N., Miller, G. E., Carrier, E. J., Gorzalka, B. B., and Hillard, C. J. (2009). Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.Psychoneuroendocrinology 34, 1257-1262. doi: 10.1016/j.psyneuen.2009.03.013
39. Ipser, J. C., and Stein, D. J. (2012). Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). Int. J. Neuropsychopharmacol. 15, 825-840. doi: 10.1017/S1461145711001209
40. Kaminski, R. M., Livingood, M. R., and Rogawski, M. A. (2004). Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia 45, 864-867. doi: 10.1111/j.0013-9580.2004.04504.x
41. Katona, I. (2009). Endocannabinoid receptors: CNS localization of the CB1 cannabinoid receptor. Curr. Top. Behav. Neurosci. 1, 65-86. doi: 10.1007/978-3-540-88955-7_3
42. Kilts, J. D., Tupler, L. A., Keefe, F. J., Payne, V. M., Hamer, R. M., Naylor, J. C.,et al. (2010). Neurosteroids and self-reported pain in veterans who served in the U.S. Military after September 11, 2001. Pain Med. 11, 1469-1476. doi: 10.1111/j.1526-4637.2010.00927.x
43. Kita, A., Kohayakawa, H., Kinoshita, T., Ochi, Y., Nakamichi, K., Kurumiya, S.,et al. (2004). Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. Br. J. Pharmacol.142, 1059-1072. doi: 10.1038/sj.bjp.0705681
44. Kobilo, T., Hazvi, S., and Dudai, Y. (2007). Role of cortical cannabinoid CB1 receptor in conditioned taste aversion memory. Eur. J. Neurosci. 25, 3417-3421. doi: 10.1111/j.1460-9568.2007.05561.x
45. Kliewer, S. A., Goodwin, B., and Willson, T. M. (2002). The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr. Rev. 23, 687-702. doi: 10.1210/er.2001-0038
46. Kudagi, B. L., Pravin, R., Kumar, S. K., and Basha, S. (2012). Evaluation of anti-anxiety, sedative and motor co-ordination properties of ganaxolone in comparison with diazepam in rodent models IOSR. J. Dental Med. Sci. 1, 42-47.
47. Kugaya, A., Sanacora, G., Verhoeff, N. P., Fujita, M., Mason, G. F., Seneca, N. M.,et al. (2003). Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT. Biol. Psychiatry 54, 792-799. doi: 10.1016/S0006-3223(02)01788-2
48. Lin, H. C., Mao, S. C., and Gean, P. W. (2006). Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle. Learn. Mem. 13, 316-321. doi: 10.1101/lm.217006
49. Lin, H. C., Mao, S. C., Su, C. L., and Gean, P. W. (2009). The role of prefrontal cortex CB1 receptors in the modulation of fear memory. Cereb. Cortex 19, 165-175. doi: 10.1093/cercor/bhn075
50. Lambert, J. J., Belelli, D., Peden, D. R., Vardy, A. W., and Peters, J. A. (2003). Neurosteroid modulation of GABAreceptors. Prog. Neurobiol. 71, 67-80. doi: 10.1016/j.pneurobio.2003.09.001
51. Marshall, R. D., Beebe, K. L., Oldham, M., and Zaninelli, R. (2001). Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am. J. Psychiatry 158, 1982-1988. doi: 10.1176/appi.ajp.158.12.1982
52. Martijena, I. D., Rodríguez Manzanares, P. A., Lacerra, C., and Molina, V. A. (2002). Gabaergic modulation of the stress response in frontal cortex and amygdala. Synapse 45, 86-94. doi: 10.1002/syn.10085
53. Matsumoto, K., Uzunova, V., Pinna, G., Taki, K., Uzunov, D. P., Watanabe, H.,et al. (1999). Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss. Neuropharmacology 38, 955-963. doi: 10.1016/S0028-3908(99)00018-0
54. Myers, K. M., and Davis, M. (2007). Mechanisms of fear extinction. Mol. Psychiatry 12, 120-150. doi: 10.1038/sj.mp.4001939
55. Mihalek, R. M., Banerjee, P. K., Korpi, E. R., Quinlan, J. J., Firestone, L. L., Mi, Z. P.,et al. (1999). Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc. Natl. Acad. Sci. U.S.A. 96, 12905-12910. doi: 10.1073/pnas.96.22.12905
56. Milad, M. R., Orr, S. P., Lasko, N. B., Chang, Y., Rauch, S. L., and Pitman, R. K. (2008). Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. J. Psychiatric Res. 42, 515-520. doi: 10.1016/j.jpsychires.2008.01.017
57. Mitchell, S. J., and Silver, R. A. (2003). Shunting inhibition modulates neuronal gain during synaptic excitation.Neuron 38, 433-445. doi: 10.1016/S0896-6273(03)00200-9
58. Mody, I., and Pearce, R. A. (2004). Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends Neurosci. 27, 569-575. doi: 10.1016/j.tins.2004.07.002
59. Mou, L., Heldt, S. A., and Ressler, K. J. (2011). Rapid brain-derived neurotrophic factor-dependent sequestration of amygdala and hippocampal GABA(A) receptors via different tyrosine receptor kinase B-mediated phosphorylation pathways. Neuroscience 176, 72-85. doi: 10.1016/j.neuroscience.2010.12.041
60. Nelson, M., and Pinna, G. (2011). S-norfluoxetine microinfused into the basolateral amygdala increases allopregnanolone levels and reduces aggression in socially isolated mice. Neuropharmacology 6, 1154-1159. doi: 10.1016/j.neuropharm.2010.10.011
61. Nin Schuler, M., Martinez, L. A., Thomas, R., Nelson, M., and Pinna, G. (2011). Allopregnanolone and S-norfluoxetine decrease anxiety-like behavior in a mouse model of anxiety/depression. Trab. Inst. Cajal 83, 215-216.
62. O'Sullivan, S. E. (2007). Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br. J. Pharmacol. 152, 576-582. doi: 10.1038/sj.bjp.0707423
63. Panahi, Y., Moghaddam, B. R., Sahebkar, A., Nazari, M. A., Beiraghdar, F., Karami, G.,et al. (2011). A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol. Med. 41, 2159-2166. doi: 10.1017/S0033291711000201
64. Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J. J., Lindemann, P.,et al. (2006). Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402-409. doi: 10.1016/j.tips.2006.06.005
65. Pibiri, F., Nelson, M., Guidotti, A., Costa, E., and Pinna, G. (2008). Decreased allopregnanolone content during social isolation enhances contextual fear: a model relevant for posttraumatic stress disorder. Proc. Natl. Acad. Sci. U.S.A. 105, 5567-5572. doi: 10.1073/pnas.0801853105
66. Pinna, G. (2010). In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis. Behav. Pharmacol.21, 438-450. doi: 10.1097/FBP.0b013e32833d8ba0
67. Pinna, G. (2014). Targeting neurosteroidogenesis as therapy for PTSD. Front. Pharmacol. 4:166. doi: 10.3389/fphar.2013.00166
68. Pinna, G., Agis-Balboa, R., Pibiri, F., Nelson, M., Guidotti, A., and Costa, E. (2008). Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice. Neurochem. Res. 33, 1990-2007. doi: 10.1007/s11064-008-9718-5
69. Pinna, G., Costa, E., and Guidotti, A. (2005). Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior. Proc. Natl. Acad. Sci. U.S.A. 102, 2135-2140. doi: 10.1073/pnas.0409643102
70. Pinna, G., Costa, E., and Guidotti, A. (2006a). Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl.) 186, 362-372. doi: 10.1007/s00213-005-0213-2
71. Pinna, G., Agis-Balboa, R. C., Zhubi, A., Matsumoto, K., Grayson, D. R., Costa, E.,et al. (2006b). Imidazenil and diazepam increase locomotor activity in mice exposed to protracted social isolation. Proc. Natl. Acad. Sci. U.S.A.103, 4275-4280. doi: 10.1073/pnas.0600329103
72. Pinna, G., Dong, E., Matsumoto, K., Costa, E., and Guidotti, A. (2003). In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc. Natl. Acad. Sci. U.S.A.100, 2035-2040. doi: 10.1073/pnas.0337642100
73. Pinna, G., Galici, R., Schneider, H. H., Stephens, D. N., and Turski, L. (1997). Alprazolam dependence prevented by substituting with the beta-carboline abecarnil. Proc. Natl. Acad. Sci. U.S.A. 94, 2719-2723. doi: 10.1073/pnas.94.6.2719
74. Pinna, G., and Rasmusson, A. M. (2012). Up-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorder. J. Neuroendocrinol.24, 102-116. doi: 10.1111/j.1365-2826.2011.02234.x
75. Pistis, M., and Melis, M. (2010). From surface to nuclear receptors: the endocannabinoid family extends its assets.Curr. Med. Chem. 17, 1450-1467. doi: 10.2174/092986710790980014
76. Puia, G., Santi, M. R., Vicini, S., Pritchett, D. B., Purdy, R. H., Paul, S. M.,et al. (1990). Neurosteroids act on recombinant human GABA receptors. Neuron 4, 759-765. doi: 10.1016/0896-6273(90)90202-Q
77. Puia, G., Vicini, S., Seeburg, P. H., and Costa, E. (1991). Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents. Mol. Pharmacol. 39, 691-696.
78. Qiu, Z. K., Zhang, L. M., Zhao, N., Chen, H. X., Zhang, Y. Z., Liu, Y. Q.,et al. (2013). Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 45, 40-46. doi: 10.1016/j.pnpbp.2013.04.010
79. Rademacher, D. J., Meier, S. E., Shi, L., Ho, W. S., Jarrahian, A., and Hillard, C. J. (2008). Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 54, 108-116. doi: 10.1016/j.neuropharm.2007.06.012
80. Rasmusson, A. M., Pinna, G., Paliwal, P., Weisman, D., and Gottshalk, C. (2006). Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol. Psychiatry 60, 704-713. doi: 10.1016/j.biopsych.2006.03.026
81. Rasmusson, A. M., Schnurr, P., Zukowska, Z., Scioli, E., and Forman, D. E. (2010). Adaptation to extreme stress: PTSD, NPY, and metabolic syndrome. Exp. Biol. Med. 235, 1150-1156. doi: 10.1258/ebm.2010.009334
82. Rasmusson, A. M., and Shalev, A. (2014). "Integrating the neuroendocrinology, neurochemistry, and neuroimmunology of PTSD to date and the challenges ahead", in Handbook of PTSD 2nd Edn. eds M. Friedman, T. Keane, and P. Resick (New York, NY: Guilford Publications Inc.), 166-189.
83. Reddy, D. S., and Rogawski, M. A. (2010). Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res. 89, 254-260. doi: 10.1016/j.eplepsyres.2010.01.009
84. Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N.,et al. (2010). Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 9, 971-988. doi: 10.1038/nrd3295
85. Rupprecht, R., Rammes, G., Eser, D., and Baghai, T. C. (2009). Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325, 490-493. doi: 10.1126/science.1175055
86. Sasso, O., La Rana, G., Vitiello, S., Russo, R., D'Agostino, G., and Iacono, A. (2010). Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice: involvement of allopregnanolone biosynthesis. Eur. Neuropsychopharmacol. 20, 195-206 doi: 10.1016/j.euroneuro.2009.09.003
87. Sasso, O., Russo, R., Vitiello, S., Raso, G. M., D'Agostino, G., Iacono, A.,et al. (2012). Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain. Pain 153, 33-41. doi: 10.1016/j.pain.2011.08.010
88. Schüle, C., Eser, D., Baghai, T. C., Nothdurfter, C., Kessler, J. S., and Rupprecht, R. (2011). Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience 191, 55-77. doi: 10.1016/j.neuroscience.2011.03.025
89. Schüle, C., Nothdurfter, C., and Rupprecht, R. (2014). The role of allopregnanolone in depression and anxiety.Prog. Neurobiol. 113, 79-87. doi: 10.1016/j.pneurobio.2013.09.003
90. Scioli-Salter, E. R., Otis, J. D., Forman, D. E., Gregor, K., Valovski, I., and Rasmusson, A. M. (2014). The shared neuroanatomy and neurobiology of comorbid chronic pain & PTSD: therapeutic implications. Clin. J. Pain doi: 10.1097/AJP.0000000000000115 [Epub ahead of print].
91. Semyanov, A., Walker, M. C., and Kullmann, D. M. (2003). GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat. Neurosci. 6, 484-490. doi: 10.1038/nn1043
92. Semyanov, A., Walker, M. C., Kullmann, D. M., and Silver, R. A. (2004). Tonically active GABA receptors: modulating gain and maintaining the tone. Trends Neurosci. 27, 262-269. doi: 10.1016/j.tins.2004.03.005
93. Slanina, K. A., and Schweitzer, P. (2005). Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus. Neuropharmacology 49, 653-659. doi: 10.1016/j.neuropharm.2005.04.019
94. Smith, S. S., Gong, Q. H., Li, X., Moran, M. H., Bitran, D., Frye, C. A.,et al. (1998). Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABA-gated current and increases the GABA receptor alpha4 subunit in association with increased anxiety. J. Neurosci. 18, 5275-5284.
95. Stern, C. A., Gazarini, L., Takahashi, R. N., Guimarães, F. S., and Bertoglio, L. J. (2012). On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment. Neuropsychopharmacology 37, 2132-2142. doi: 10.1038/npp.2012.63
96. Sun, C., Sieghart, W., and Kapur, J. (2004). Distribution of alpha1, alpha4, gamma2, and delta subunits of GABAreceptors in hippocampal granule cells. Brain Res. 1029, 207-216. doi: 10.1016/j.brainres.2004.09.056
97. Sundstrom-Poromaa, I., Smith, D. H., Gong, Q. H., Sabado, T. N., Li, X., Light, A.,et al. (2002). Hormonally regulated alpha(4)beta(2)delta GABA(A) receptors are a target for alcohol. Nat. Neurosci. 5, 721-722. doi: 10.1038/nn888
98. Suzuki, A., Mukawa, T., Tsukagoshi, A., Frankland, P. W., and Kida, S. (2008). Activation of LVGCCs and CB1 receptors required for destabilization of reactivated contextual fear memories. Learn. Mem. 15, 426-433. doi: 10.1101/lm.888808
99. Tucker, P., Zaninelli, R., Yehuda, R., Ruggiero, L., Dillingham, K., and Pitts, C. D. (2001). Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J. Clin. Psychiatry 62, 860-868. doi: 10.4088/JCP.v62n1105
100. Umathe, S. N., Manna, S. S., and Jain, N. S. (2011). Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. Behav. Brain Res. 223, 125-134. doi: 10.1016/j.bbr.2011.04.031
101. Uz, T., Dimitrijevic, N., Akhisaroglu, M., Imbesi, M., Kurtuncu, M., and Manev, H. (2004). The pineal gland and anxiogenic-like action of fluoxetine in mice. Neuroreport 15, 691-694. doi: 10.1097/00001756-200403220-00023
102. Uzunova, V., Sheline, Y., Davis, J. M., Rasmusson, A., Uzunov, D. P., Costa, E.,et al. (1998). Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. U.S.A. 95, 3239-3244. doi: 10.1073/pnas.95.6.3239
103. Vaiva, G., Thomas, P., Ducrocq, F., Fontaine, M., Boss, V., Devos, P.,et al. (2004). Low posttrauma GABA plasma levels as a predictive factor in the development of acute posttraumatic stress disorder. Biol. Psychiatry 55, 250-254. doi: 10.1016/j.biopsych.2003.08.009
104. Vallée, M., Vitiello, S., Bellocchio, L., Hébert-Chatelain, E., Monlezun, S., Martin-Garcia, E.,et al. (2014). Pregnenolone can protect the brain from cannabis intoxication. Science 343, 94-98. doi: 10.1126/science.1243985
105. Walderhaug, E., Kasserman, S., Aikins, D., Vojvoda, D., Nishimura, C., and Neumeister, A. (2010). Effects of duloxetine in treatment-refractory men with posttraumatic stress disorder. Pharmacopsychiatry 43, 45-49. doi: 10.1055/s-0029-1237694
106. Westenberg, H. G. M. (1996). Development in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors? J. Affect. Dis. 40, 85-93. doi: 10.1016/0165-0327(96)00043-2
107. Yu, H. L., Deng, X. Q., Li, Y. J., Li, Y. C., Quan, Z. S., and Sun, X. Y. (2011). N-palmitoylethanolamide, an endocannabinoid exhibits antidepressant effects in the forced swim test and the tail suspension test in mice.Pharmacol. Rep. 63, 834-839. doi: 10.1016/S1734-1140(11)70596-5
108. Zohar, J., Amital, D., Miodownik, C., Kotler, M., Bleich, A., Lane, R. M.,et al. (2002). Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J. Clin. Psychopharmacol. 22, 190-195. doi: 10.1097/00004714-200204000-00013